NEXGEL, Inc. (NXGL) Financials
NXGL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 26.4 million | 21.0 million |
| March 31, 2026 | 11.6 million | 7.1 million |
| Dec. 31, 2025 | 10.5 million | 5.6 million |
| Sept. 30, 2025 | 11.6 million | 6.0 million |
NXGL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -2.3 million | 119000 |
| March 31, 2026 | -513000 | 143000 |
| Dec. 31, 2025 | 309000 | 156000 |
| Sept. 30, 2025 | -793000 | 205000 |
NXGL Net Income
No data available :(
NXGL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 492000 | 3.5 million | 3.1 million |
| March 31, 2026 | 208000 | 1.8 million | 2.4 million |
| Dec. 31, 2025 | 317000 | 489000 | 2.5 million |
| Sept. 30, 2025 | 938000 | 515000 | 2.6 million |
NXGL Shares Outstanding
NXGL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 76000 | 20000 | 3.6 million | - |
| March 31, 2026 | 9000 | - | 2.0 million | - |
| Dec. 31, 2025 | 28000 | 6000 | 2.0 million | 1.3 million |
| Sept. 30, 2025 | 8000 | 7000 | 1.9 million | 650000 |
NXGL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 3.7 million | 2.6 million |
| March 31, 2026 | 2.7 million | 1.6 million |
| Dec. 31, 2025 | 2.8 million | 2.0 million |
| Sept. 30, 2025 | 2.9 million | 1.7 million |
NXGL Revenue by Segment
Graph available only for paid members. Upgrade to see it.
NXGL
Price: $0.29
52 week price:
Earnings Per Share: -0.74 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 3300
Market Capitalization: 2.9 million